ULTRAGENYX PHARMACEUTICAL IN

Ticker: RARE CUSIP: 90400D108 Class: EQTY

Avoro Capital Advisors LLC's Holding History (CIK: 0001633313)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025
Shares 330,000 Value ($000) $11,999 Avg Close $36.05 Range $29.59 - $40.19
Q1 2025
Shares 830,000 Value ($000) $30,054 Avg Close $41.60 Range $35.53 - $46.50
Q4 2024
Shares 830,000 Value ($000) $34,918 Avg Close $49.61 Range $41.26 - $57.99
Q3 2024
Shares 830,000 Value ($000) $46,107 Avg Close $50.94 Range $39.65 - $60.37
Q2 2024
Shares 830,000 Value ($000) $34,113 Avg Close $42.70 Range $37.02 - $52.56
Q1 2024
Shares 830,000 Value ($000) $38,753 Avg Close $47.17 Range $41.87 - $54.56
Q4 2023
Shares 350,000 Value ($000) $16,737 Avg Close $38.77 Range $31.52 - $49.93
Q3 2023
Shares 1,500,000 Value ($000) $53,475 Avg Close $39.62 Range $34.33 - $47.08
Q2 2023
Shares 750,000 Value ($000) $34,598 Avg Close $46.38 Range $37.20 - $54.98
Q1 2023
Shares 750,000 Value ($000) $30,075 Avg Close $42.91 Range $35.72 - $49.31
Q4 2022
Shares 750,000 Value ($000) $34,748 Avg Close $39.33 Range $33.36 - $46.51
Q3 2022
Shares 750,000 Value ($000) $31,058 Avg Close $51.39 Range $39.55 - $68.68
Q2 2022
Shares 750,000 Value ($000) $44,745 Avg Close $61.54 Range $45.20 - $85.53
Q1 2022
Shares 230,000 Value ($000) $16,703 Avg Close $69.58 Range $61.20 - $88.12